Biotech & Bioprocessing

Glucose Discovered as Key Regulator of Tissue Differentiation
Biotech & Bioprocessing Glucose Discovered as Key Regulator of Tissue Differentiation

Glucose, a simple sugar widely recognized for its role as the primary energy source for most living cells, has recently been discovered to play a critical role beyond its conventional function. In groundbreaking research conducted by a team at Stanford Medicine, glucose has been identified as a

March 26, 2025
Avian Influenza Found in Yorkshire Sheep Prompts Increased Biosecurity Steps
Biotech & Bioprocessing Avian Influenza Found in Yorkshire Sheep Prompts Increased Biosecurity Steps

The National Farmers' Union (NFU) has recently called for enhanced biosecurity measures among farmers after detecting a case of avian influenza (H5N1) in a sheep in Yorkshire. This discovery came to light following routine surveillance, wherein avian influenza had previously been confirmed in

March 25, 2025
Should We Alter an Unborn Child's Sexual Orientation with Genetic Engineering?
Biotech & Bioprocessing Should We Alter an Unborn Child's Sexual Orientation with Genetic Engineering?

The notion of genetically engineering an unborn child's sexual orientation has stirred debates among ethicists, scientists, and religious groups. This discourse stems from the suggestion that, with advancements in scientific knowledge, it might be possible to determine an unborn child's

March 24, 2025
Saudi Arabia and GCC Countries Aim to Lead in Biotech by 2030
Biotech & Bioprocessing Saudi Arabia and GCC Countries Aim to Lead in Biotech by 2030

The COVID-19 pandemic underscored significant challenges that tested the resilience of the global biotech industry, causing unprecedented disruptions but also highlighting areas ripe for growth and innovation. Against this backdrop, the Gulf Cooperation Council (GCC) countries, with Saudi Arabia at

March 21, 2025
GRObio Faces IP Conflicts and Investor Uncertainty Amidst Restructuring
Biotech & Bioprocessing GRObio Faces IP Conflicts and Investor Uncertainty Amidst Restructuring

GRObio, a spinout from the George Church Lab at Harvard University, has encountered significant hurdles lately. Founded in 2016, GRObio focuses on developing therapeutic proteins built on nonstandard amino acids (NSAAs). Despite its pioneering approach, the company is undergoing a period of

March 20, 2025
Ori Biotech Launches Network to Accelerate Cell Therapy Development
Biotech & Bioprocessing Ori Biotech Launches Network to Accelerate Cell Therapy Development

Ivan Kairatov is a Biopharma expert, with deep knowledge of tech and innovation in the industry and experience in research and development. He joins us today to discuss Ori Biotech’s new Preferred Partner Network (PPN), the collaboration with various organizations, and the impacts on cell therapy d

March 19, 2025
Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later